Cargando…
Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes
BACKGROUND: Lysophosphatidic acid (LPA) is a bioactive phospholipid with a potentially causative role in neurotrauma. Blocking LPA signaling with the LPA-directed monoclonal antibody B3/Lpathomab is neuroprotective in the mouse spinal cord following injury. FINDINGS: Here we investigated the use of...
Autores principales: | Crack, Peter J, Zhang, Moses, Morganti-Kossmann, Maria Cristina, Morris, Andrew J, Wojciak, Jonathan M, Fleming, Jonathan K, Karve, Ila, Wright, David, Sashindranath, Maithili, Goldshmit, Yona, Conquest, Alison, Daglas, Maria, Johnston, Leigh A, Medcalf, Robert L, Sabbadini, Roger A, Pébay, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996049/ https://www.ncbi.nlm.nih.gov/pubmed/24576351 http://dx.doi.org/10.1186/1742-2094-11-37 |
Ejemplares similares
-
Ablation of Type-1 IFN Signaling in Hematopoietic Cells Confers Protection Following Traumatic Brain Injury123
por: Karve, Ila P., et al.
Publicado: (2016) -
Role of ectonucleotide pyrophosphatase/phosphodiesterase 2 in the midline axis formation of zebrafish
por: Frisca, Frisca, et al.
Publicado: (2016) -
Endothelial Dysfunction in the Brain: Setting the Stage for Stroke and Other Cerebrovascular Complications of COVID-19
por: Sashindranath, Maithili, et al.
Publicado: (2021) -
Antibodies Against Lysophosphatidic Acid Protect Against Blast-Induced Ocular Injuries
por: Arun, Peethambaran, et al.
Publicado: (2020) -
CD39 in the development and progression of pulmonary arterial hypertension
por: Willcox, Abbey, et al.
Publicado: (2022)